Litcius/Paper detail

Laboratory Abnormalities in Pregnant Women with Novel Coronavirus Disease 2019

Li Shi, Ying Wang, Haiyan Yang, Guangcai Duan, Yadong Wang

2020American Journal of Perinatology23 citationsDOIOpen Access PDF

Abstract

Novel coronavirus disease 2019 (COVID-19), sustained by the causative agent called severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), is highly contagious.[1] [2] At present, above 2 million confirmed cases and over 170,000 deaths of COVID-19 have occurred in the world according to the World Health Organization.[3] Pregnant women, because of their special physiological conditions, are susceptible to the virus and put themselves at greater risk.[4] Timely control and treatment of pregnant women with COVID-19 infection are a major concern.[5] Moreover, laboratory medicine plays a vital role in this process.[6] Therefore, the purpose of this article is to identify the most common laboratory abnormalities in pregnant women with COVID-19.

Topics & Concepts

MedicineCoronavirusCoronavirus disease 2019 (COVID-19)DiseasePregnancySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicinePandemic2019-20 coronavirus outbreakBetacoronavirusVirusPediatricsVirologyInfectious disease (medical specialty)Internal medicineOutbreakGeneticsBiologyCOVID-19 Impact on ReproductionCOVID-19 and healthcare impactsCOVID-19 Clinical Research Studies